Download PDF
Am J Perinatol 2016; 33(11): 1085-1089
DOI: 10.1055/s-0036-1586105
Original Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Lactoferrin Levels in Human Milk after Preterm and Term Delivery

Marzia Albenzio
1   Department of the Sciences of Agriculture, Food and Environment, University of Foggia, Foggia, Italy
,
Antonella Santillo
1   Department of the Sciences of Agriculture, Food and Environment, University of Foggia, Foggia, Italy
,
Ilaria Stolfi
2   Department of Neonatology and Neonatal Intensive Care Unit, Umberto I Policlinico of Rome, Rome, Italy
,
Paolo Manzoni
3   Department of Neonatology and Neonatal Intensive Care Unit, S. Anna Hospital, Turin, Italy
,
Alice Iliceto
1   Department of the Sciences of Agriculture, Food and Environment, University of Foggia, Foggia, Italy
,
Matteo Rinaldi
4   Department of Neonatology and Neonatal Intensive Care Unit, Ospedali Riuniti, Foggia, Italy
,
Rosario Magaldi
4   Department of Neonatology and Neonatal Intensive Care Unit, Ospedali Riuniti, Foggia, Italy
› Author Affiliations
Further Information

Publication History

Publication Date:
07 September 2016 (online)

    Permissions and Reprints

Abstract

Background Lactoferrin (LF) is a highly represented, functional glycoprotein in human milk, exerting a wide range of anti-infective, immunomodulatory, and prebiotic actions in the neonate. Limited data are available assessing the concentrations and levels of LF in maternal milk over time during lactation in mothers who delivered infants at different GAs. Our aim with the present study was to determine the levels of LF in human milk from mothers of preterm and term infants and to evaluate the variations at a different time from delivery, in colostrum and mature milk.

Methods Mothers of preterm and term infants from the Neonatology Unit in Foggia, Italy, were approached and enrolled in this study. From each mother, milk samples were collected within the first 3 days after birth (group A, 0–72 hours), between the 5th and 7th day after delivery (group B, 120–168 hours), and after the 10th day (group C, > 240 hours). All milk samples were divided into five groups, according to the GA of the infants: 24 to 27.6 weeks of GA (I), 28 to 31.6 weeks of GA (II), 32 to 34.6 weeks of GA (III), 35 to 37.6 weeks of GA (IV), and > 38 weeks of GA (V). Milk samples were analyzed by sodium dodecyl sulfate-polyacrylamide gel electrophoresis to determine the content of LF.

Results A total of 84 milk samples were collected from 28 mothers. We found that infant's GA, as well as the time of sampling, affected the levels of LF in milk. On one hand, LF showed higher content in human milk from group I (GA: 24–27.6 weeks) compared with the other groups (p < 0.01), and the levels of LF in colostrum were significantly correlated with GA (r = −0.31; p < 0.05). On the other hand, the LF content of milk had a significant decreasing trend over time. Overall, the highest values of LF were detected in preterm infants' maternal milk with a baby birth weight, lower than 1,400 g. Approximately 350 µg/mL was identified as the mean, physiological LF content in human mature milk in our population.

Conclusions Levels of LF in human milk vary significantly over time during lactation and according to GA. This variability in the LF content of human milk may reflect the different needs of different infants during the early days and weeks of life. These data might help to inform models to design tailored supplementation strategies of LF in the nurseries and after home discharge.

Keywords

lactoferrin - human milk - neonate - infant - sepsis - preterm
 

  • References

  • 1 American Academy of Pediatrics. Work Group on Breastfeeding. Breastfeeding and the use of human milk. Pediatrics 1997; 100 (06) 1035-1039
    CrossrefPubMedGoogle Scholar
  • 2 Clare DA, Catignani GL, Swaisgood HE. Biodefense properties of milk: the role of antimicrobial proteins and peptides. Curr Pharm Des 2003; 9 (16) 1239-1255
    CrossrefPubMedGoogle Scholar
  • 3 Florisa R, Recio I, Berkhout B, Visser S. Antibacterial and antiviral effects of milk proteins and derivatives thereof. Curr Pharm Des 2003; 9 (16) 1257-1275
    CrossrefPubMedGoogle Scholar
  • 4 Bernt KM, Walker WA. Human milk as a carrier of biochemical messages. Acta Paediatr Suppl 1999; 88 (430) 27-41
    CrossrefPubMedGoogle Scholar
  • 5 Lönnerdal B. Infant formula and infant nutrition: bioactive proteins of human milk and implications for composition of infant formulas. Am J Clin Nutr 2014; 99 (03) 712S-717S
    CrossrefPubMedGoogle Scholar
  • 6 Buccigrossi V, de Marco G, Bruzzese E. , et al. Lactoferrin induces concentration-dependent functional modulation of intestinal proliferation and differentiation. Pediatr Res 2007; 61 (04) 410-414
    CrossrefPubMedGoogle Scholar
  • 7 Mastromarino P, Capobianco D, Campagna G. , et al. Correlation between lactoferrin and beneficial microbiota in breast milk and infant's feces. Biometals 2014; 27 (05) 1077-1086
    CrossrefPubMedGoogle Scholar
  • 8 Manzoni P, De Luca D, Stronati M. , et al. Prevention of nosocomial infections in neonatal intensive care units. Am J Perinatol 2013; 30 (02) 81-88
    Article in Thieme ConnectPubMedGoogle Scholar
  • 9 Wagner CL. Human milk and lactation. Available at: http://emedicine.medscape.com/article/1835675-overview#showall . Accessed May 21, 2015
    PubMedGoogle Scholar
  • 10 Ronayne de Ferrer PA, Baroni A, Sambucetti ME, López NE, Ceriani Cernadas JM. Lactoferrin levels in term and preterm milk. J Am Coll Nutr 2000; 19 (03) 370-373
    CrossrefPubMedGoogle Scholar
  • 11 Laemmli UK. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 1970; 227 (5259): 680-685
    CrossrefPubMedGoogle Scholar
  • 12 Blakesley RW, Boezi JA. A new staining technique for proteins in polyacrylamide gels using coomassie brilliant blue G250. Anal Biochem 1977; 82 (02) 580-582
    CrossrefPubMedGoogle Scholar
  • 13 Shapiro SS, Wilk M. An analysis of variance test for normality. Biometrika 1965; 52: 591-611
    CrossrefPubMedGoogle Scholar
  • 14 SAS Institute Inc. SAS User's Guide: Statistics. Version 9.2. Cary, NC: SAS Institute Inc.; 2011
    Google Scholar
  • 15 Mills S, Ross RP, Hill C, Fitzgerald GF, Stanton C. Milk intelligence: mining milk for bioactive substances associated with human health. Int Dairy J 2011; 21 (06) 377-401
    CrossrefPubMedGoogle Scholar
  • 16 Appelmelk BJ, An YQ, Geerts M. , et al. Lactoferrin is a lipid A-binding protein. Infect Immun 1994; 62 (06) 2628-2632
    PubMedGoogle Scholar
  • 17 Queiroz VA, Assis AM. , R Júnior HdaC. Protective effect of human lactoferrin in the gastrointestinal tract. Rev Paul Pediatr 2013; 31 (01) 90-95
    CrossrefPubMedGoogle Scholar
  • 18 Albenzio M, Santillo A, Russo DE, Rinaldi M, Minelli G, Magaldi R. Lactoferrin measuring in term and preterm milk. Presented at: the 3rd Human Milk Banking Meeting; October 16, 2010; Milan, Italy
    PubMedGoogle Scholar
  • 19 Rai D, Adelman AS, Zhuang W, Rai GP, Boettcher J, Lönnerdal B. Longitudinal changes in lactoferrin concentrations in human milk: a global systematic review. Crit Rev Food Sci Nutr 2014; 54 (12) 1539-1547
    CrossrefPubMedGoogle Scholar
  • 20 Manzoni P, Rinaldi M, Cattani S. , et al; Italian Task Force for the Study and Prevention of Neonatal Fungal Infections, Italian Society of Neonatology. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA 2009; 302 (13) 1421-1428
    CrossrefPubMedGoogle Scholar
  • 21 Manzoni P. Clinical benefits of lactoferrin for infants and children. J Pediatr 2016; 173 (Suppl): S43-S52
    CrossrefPubMedGoogle Scholar